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Abstract
Background: The presentation of new influenza A(H1N1) is broad and evolving as it continues to affect different geographic
locations and populations. To improve the accuracy of predicting influenza infection in an outpatient setting, we undertook
a comparative analysis of H1N1(2009), seasonal influenza, and persons with acute respiratory illness (ARI) in an outpatient
setting.
Methodology/Principal Findings: Comparative analyses of one hundred non-matched cases each of PCR confirmed
H1N1(2009),seasonalinfluenza, andARIcases.Multivariateanalysiswasperformedtolook forpredictorsof influenzainfection.
Receiver operating characteristic curves were constructed for various combinations of clinical and laboratory case definitions.
The initial clinical and laboratory features of H1N1(2009) and seasonal influenza were similar. Among ARI cases, fever, cough,
headache, rhinorrhea, the absence of leukocytosis, and a normal chest radiograph positively predict for both PCR-confirmed
H1N1-2009 and seasonal influenza infection. The sensitivity and specificity of current WHO and CDC influenza-like illness (ILI)
criteria were modest in predicting influenza infection. However, the combination of WHO ILI criteria with the absence of
leukocytosis greatly improved the accuracy of diagnosing H1N1(2009) and seasonal influenza (positive LR of 7.8 (95%CI 3.5–
17.5) and 9.2 (95%CI 4.1–20.3) respectively).
Conclusions/Significance: The clinical presentation of H1N1(2009) infection is largely indistinguishable from that of seasonal
influenza. Among patients with acute respiratory illness, features such as a temperature greater than 38uC, rhinorrhea, a normal
chest radiograph, and the absence of leukocytosis or significant gastrointestinal symptoms were all positively associated with
H1N1(2009) and seasonal influenza infection. An enhanced ILI criteria that combines both a symptom complex with the
absence of leukocytosis on testing can improve the accuracy of predicting both seasonal and H1N1-2009 influenza infection.
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Introduction
A novel influenza of swine origin, designated as new influenza A
(H1N1), emerged in late April 2009. Since then, it has spread
globally resulting in the first new pandemic of the 21
st century.
The initial epidemiology and presentation of the disease has been
notable for severe respiratory disease and mortality in persons less
than 60 years and with co-morbidities [1,2]. Its presentation is
however broad and evolving as it continues to affect different
geographic locations and populations.
From a health perspective, differentiating the new influenza
A(H1N1) (hence referred to as H1N1(2009)) and influenza viruses
from other pathogens presenting with symptoms of acute
respiratory illness (ARI) is valuable. Making such a distinction
serves to both improve individual case management—given the
availability of safe and effective anti-influenza drugs to which
H1N1(2009) remains presently largely susceptible to—and to
augment wider public health surveillance and mitigation measures
[1,2,3]. The clinical diagnosis of influenza infection is however
often elusive given its non-specific presentation. The use of a simple
symptom complex for influenza-like illnesses (ILI) at the primary
care level can serve as convenient predictive tools for influenza
infection, especially in the setting of an influenza community
outbreak. However the sensitivity and positive predictive value of
such symptom complexes or definitions vary widely depending on
the prevalence of disease and population tested [4].
We undertook this study to better define the clinical and
laboratory presentation of H1N1(2009) in an acute care outpatient
setting. In addition, we sought to identify predictors of H1N1(2009)
infection and validate the use of current clinical case definitions for
influenza-like illness in predicting both H1N1(2009) and seasonal
influenza.
Methods
We conducted a retrospective review on the outpatient
presentation of adult patients seen at the Tan Tock Seng Hospital
(TTSH) for suspect influenza in the ‘‘containment period’’ of the
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8453H1N1(2009) epidemic in Singapore. TTSH is a 1500-bed tertiary
hospital in Singapore and was designated the primary national
center for adult influenza screening, treatment and isolation of
H1N1(2009) cases. In line with enhanced surveillance and public
health control measures during the containment period, the
Ministry of Health instructed that all travelers returning from
H1N1(2009) affected areas with ARI symptoms were to be
referred to the hospital for screening and evaluation [5,6].
Contacts of such patients were also to be referred to the hospital
for H1N1(2009) screening. All patients had clinical samples
collected at presentation for complete blood counts, serum
chemistry and a chest radiograph (CXR). Two sets of nasal/
throat swabs for influenza testing were collected from each patient.
During the containment period, patients testing negative on
influenza PCR were discharged if clinically stable, while all PCR-
confirmed H1N1(2009) cases were admitted to the hospital for
quarantine until negative nasal/throat viral shedding had been
documented on serial PCR tests.
We selected our patients using a hospital influenza screening
database of adult patients (age.=16 years) seen during the
epidemic containment period, which lasted from 27 Apr 2009 till
end of June 2009. We included the first 100 consecutive adult
cases of PCR-confirmed 2009-H1N1, and then used random
number generators to sample one hundred non-matched cases of
seasonal influenza and ARI adult patients. The patients presented
between the following dates: H1N1(2009) cases between 26 May
to 27 June 2009, seasonal influenza cases between 27 Apr to 11
June 2009 and ARI cases between 27 Apr to 11 June 2009. The
choice of date ranges was influenced by our intent to obtain a
sufficient number of patients from each group who were referred
during the epidemic containment period while accounting for two
key logistical limitations – that the first H1N1(2009) patient in
Singapore was diagnosed only on 26 May 2009, and the decision
to conserve laboratory testing policy after 11 June 2009 by testing
ARI cases only to rule out H1N1(2009) rather than against the
entire panel of seasonal influenza strains. ARI cases were defined
as anyone who had self-reported influenza-like symptoms
including chills/feverishness, cough, sore throat, headache,
rhinorrhea, and/or myalgia, with or without a documented fever
(body temperature .37.5uC. Clinical, epidemiological, radiology
and laboratory data for each patient were extracted to a
standardized clinical research form.
Ethics Statement
An expedited review by the National Healthcare Group
institutional review board of the hospital approved the study
protocol (DSRB Domain E/09/344). A waiver of consent was
obtained given the retrospective nature of the research and that
the research involved no more than minimal risk to subjects nor
involved any procedures for which written consent is normally
required outside of the research context.
Statistical Analyses
Statistical analyses were performed using STATA software
(version 10, StataCorp, Texas). The Student’s t test was used for
comparison of continuous variable, and Fisher’s exact test was
used for comparison of dichotomous variables. For data that
were not normally distributed, the Wilcoxon rank-sum test for
continuous variables was used. Variables found to be statistically
significant in uni-variate analyses were entered into multivariate
analysis using a logistic regression model to identify independent
risk factors for being H1N1(2009) positive. A two-tailed p value of
,0.05 was considered statistically significant.
We compared the performance of individual and combinations
of variables for the diagnosis of both H1N1(2009) and seasonal
influenza by using the RT-PCR as the reference standard. We
calculated the sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV), likelihood ratio (LR) for a
positive test (LRP), and LR for a negative test (LRN) with 95
percent confidence intervals (CI). LRs indicate by how much a
given diagnostic test result will raise or lower the pretest
probability of the target disorder. LRPs of .10 or LRNs of
,0.1 generate large and often conclusive changes from pretest
probability to posttest probability, LRPs of 5 to 10 and LRNs of
0.1 to 0.2 generate moderate shifts in pretest probability to posttest
probability, LRPs of 2 to 5 and LRNs of 0.2 to 0.5 generate small
(but sometimes important) changes in probability, and LRPs of 1
to 2 and LRNs of 0.5 to 1 alter probability to a small (and rarely
important) degree [7]. Receiver operating characteristic curves
were plotted for various combinations of clinical and laboratory
case definitions. The diagnostic accuracy of each parameter and
symptom combination was assessed by calculating its area under
receiver operating characteristic curves (AUROC). AUROC
analysis was used to answer the question of how accurate
combinations of symptoms, signs and investigations are in
identifying H1N1(2009) and seasonal influenza diseased patients.
Laboratory Confirmation
Combined nasal and throat flocked swabs (Copan, Italy) in RT-
UTM (Copan, Italy) were vortexed and nucleic acids extracted
with a NucliSENSH easyMAGH instrument (Biomerieux) or with
the EZ1 virus minikit v2.0 on an EZ1 Advanced XL (Qiagen).
Reverse transcription PCR (RT-PCR) was migrated across three
platforms as the pandemic progressed; a multiplex in-house gel
based method (100% sensitivity and specificity for detection and
subtyping compared with ResplexII, Qiagen, Germany), a Taq-
man based real time in-house singleplex assay specific to H1N1
(2009) run on a Lightcycler (Roche, Germany) and an in-house
Taqman based real time multiplex assay including H1N1 (2009)
specific reagents run on a Stratagene Mx3005P (Agilent, USA), (all
three assays’ manuscript in preparation for publication). Cases of
Influenza A H1N1 were confirmed as either seasonal H1N1 or as
H1N1 (2009) by the National Public Health Laboratory, with the
use of two RT-PCR assays including the CDC method,
sequencing of the matrix gene and viral culture on Madin-Darby
canine kidney cells with subsequent typing with a DFA kit
(LIGHT DIAGNOSTICS
TM, Millipore) and subtyping with
RT-PCR.
Results
Between 27 April and 11 June, a total of 983 patients presented
to the Emergency Department to be screened for influenzaThis
included 137 adults with PCR-confirmed seasonal influenza
strains presenting between the above dates (Figure 1), from which
100 patients (83 with influenza A(H3N2), 7 seasonal influenza
A(H1N1) and 10 cases of influenza B were randomly selected.
There were also 20 patients with PCR-confirmed H1N1(2009) as
of 11 June 2009, and additional cases of H1N1(2009) up to 27
June 2009 were included to make up 100 subjects for analyses.
Finally, 100 patients negative for all influenza strains were
randomly selected from the remaining influenza negative ARI
patients (presenting between 27 April and 11 June 2009).
Demographic information, underlying co-morbid conditions and
travel history of the selected patients from all three comparative
groups are presented in Table 1. The majority of the 100
laboratory-confirmed cases of H1N1(2009) presenting to the
Diagnosis of Influenza
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8453Figure 1. Date of presentation of adult H1N1(2009) and seasonal influenza cases by epidemiological week. Notethat there was inconsistent
testing for influenza strains other than H1N1(2009) after 11 June 2009 (Week 23), and the data for seasonal influenza is hence censored after week 23.
doi:10.1371/journal.pone.0008453.g001
Table 1. Demographics, co-morbidities, and history of travel.
Patient characteristics
A: H1N1
(2009)
(N=100)
B: Other
influenza strains
(N=100)
C: No influenza
on PCR
(N=100)
p-Value
Av sB Av sC Bv sC
Age in years Mean 27.2 37.6 37.3 ,0.001* ,0.001*
Range (16–56) (18–75) (20–94)
Age distribution, % ,0.001{ ,0.001{
,30 years 74% 26% 36%
30 to 49 years 21% 60% 44%
$50 years 5% 14% 20%
Male gender, % 53% 59% 47%
Ethnicity, % 0.024{
Chinese 45% 59% 64%
Malay 9% 9% 5%
Indian 7% 6% 9%
Others 39% 26% 22%
Comorbid conditions, %
Diabetes 0% 2% 5%
Hypertension/dyslipidemia 2% 9% 10% 0.033{
Asthma/bronchitis/COPD 5% 7% 8%
Childhood asthma 3% 3% 4%
Cardiovascular disease 0% 1% 4%
Immuno-compromised state 1% 2% 0%
Others 7% 10% 10%
Risk factors for severe influenza infection, %
Age $65 years 0% 5% 4%
Significant co-morbidities{ 6% 10% 14%
Significant co-morbidities or age $65{ 6% 12% 16% 0.024{
Reported travel history, % 79% 74% 93% 0.004{ ,0.001{
*2-sided p-value by Student’s t test.
{2-sided p-value by chi-squared test or Fisher’s exact test
{Includes diabetes, asthma (excluding childhood asthma), COPD (chronic obstructive pulmonary disease), chronic bronchitis, cardiovascular disease (excluding
hypertension) and conditions possibly causing an immuno-compromised state
doi:10.1371/journal.pone.0008453.t001
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The H1N1(2009) individuals were less likely to belong to a major
ethnic group of Singapore and less likely to have a co-morbid
condition. In of all three groups of patients, more than three
quarters reported recent travel outside of Singapore.
More than half of the influenza cases presented within by day 3
of illness. Self-reported feverishness was a prominent presenting
feature in individuals with either H1N1(2009) or seasonal
influenza (Table 2). Cough, sore throat and rhinorrhea at
presentation were common across all 3 groups but not myalgia
and headache; only a few had lower respiratory tract symptoms
such as dyspnea. Of patients with confirmed H1N1(2009) and
seasonal influenza, 13% and 8% respectively had leukocytosis,
whereas leukocytosis was found in approximately half of the non-
influenza cases. Lymphopenia occurred less frequently in individ-
uals with H1N1(2009) than in those with seasonal influenza (33%
vs. 55%, p=0.002) but more frequently than those without
influenza (33% vs. 16%, p=0.005). Abnormal chest radiographic
findings were not common in any of the groups.
On univariate analysis (Table 3), no single symptom, sign or
laboratory feature was strongly predictive of H1N1(2009). The
highest temperature threshold of 38.1uC or greater was most
strongly predictive of influenza (crude odds ratio (OR) 6.45, 95%CI
3.2–13.4) while nausea, vomiting and anorexia was inversely
associated with influenza (crude OR 0.1, 95%CI 0.0–0.6). On
multivariate analysis using both clinical and laboratory predictors,
H1N1(2009) patients were more likely to report feverishness, chills
or rigors (Adjusted OR (aOR)=3.8, 95%CI, 1.6–9.0); rhinorrhea
Table 2. Symptoms, clinical, laboratory, and radiological findings at presentation.
Patient characteristics
A: H1N1
(2009)
(N=100)
B: Other
influenza
strains
(N=100)
C: No
influenza
on PCR
(N=100) p-Value
Av sB Av sC Bv sC
Day of illness at presentation, %
Day 1 9% 7% 7%
Day 2 22% 22% 24%
Day 3 24% 29% 17%
Day 4 or later 45% 42% 52%
Constitutional symptoms, %
Self-reported feverishness/chills/rigors 88% 92% 53% ,0.001{ ,0.001{
Myalgia 14% 23% 12% ,0.041{
Lethargy/malaise 4% 2% 5%
Nausea/vomitting/anorexia 2% 7% 14% 0.003
Headache 19% 15% 10%
Respiratory symptoms, %
Cough 80% 84% 63% 0.008{ 0.001{
Sore throat 51% 61% 58%
Rhinorrhea/nasal congestion 60% 59% 44% 0.024{ 0.034{
Lower respiratory tract symptoms 1% 6% 6%
Other symptoms, %
D i a r r h o e a 4 %0 %9 % 0 . 0 0 3 {
Abdominal discomfort 3% 2% 6%
Heart rate ,0.001* ,0.001*
Mean 101.0 104.5 94.0
Range (70.0–196.0) (75.0–143.0) (63.0–128.0)
Body temperature ,0.001* ,0.001*
Mean 38.2 38.3 37.3
Range (36.5–39.7) (36.3–40.3) (36.0–40.1)
Body temperature, % ,0.001{ ,0.001{
T#37.4uC 24% 18% 60%
T=37.5uCt o3 7 . 7 uC 13% 8% 11%
T=37.8uCt o3 8 . 0 uC 6% 11% 12%
T$38.1uC 57% 63% 17%
Leucocytosis (leucocytes .9.3610ˆ9/L) 13% 8% 43% ,0.001{ ,0.001{
Lymphopenia (lymphocytes ,0.9610ˆ9/L) 33% 55% 16% 0.002{ 0.005{ ,0.001{
*2-sided p-value by Student’s t test.
{2-sided p-value by chi-squared test or Fisher’s exact test; only values significant at p,0.05 are shown.
doi:10.1371/journal.pone.0008453.t002
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to have a temperature of 38.1uC or higher (aOR=6.7, 95%CI,
2.7–16.7) compared to patients with ARI. The absence of
leukocytosis and a normal CXR increased the odds of having
H1N1(2009) by greater than 4 and 6 fold respectively. Nausea,
vomiting or anorexia negatively predicted for H1N1(2009) infection
(aOR=0.1, 95%CI, 0–0.3). In a separate multivariate analysis, the
same clinical and laboratory features identified as significant for
H1N1(2009) diagnosis were mostly found to be similarly important
in predicting seasonal influenza (Table 4). Key differences were that
several symptoms such as headache, nausea, vomiting or anorexia
were not found to be significant when comparing seasonal influenza
with ARI. However, higher odds ratios were observed for self-
reported feverishness and cough, and lymphopenia was found to be
a significant discriminator for seasonal influenza. In multivariate
analysis, adding basic laboratory features and CXR findings
marginally but significantly improved our ability to discriminate
both H1N1(2009) and seasonal influenza from ARI (p=0.03 and
p=0.006 respectively), as illustrated by the AUROC plots in
Figure 2.
Table 5 gives the likelihood ratios for key variables significantly
associated with influenza infection. Body temperature of 38.1uCo r
more was the single variable best able to distinguish ARIs, but the
LRP and LRN values indicate that it could at best generate small
changes in posttest probabilities. Table 5 also presents results for
combinations of symptoms and laboratory criteria.
Forty percent of all H1N1 participants presented with
symptoms that met the WHO’s criteria for influenza-like illness,
i.e. presence of fever (temperature .38.0C) and an upper
respiratory symptoms such as cough or sore throat. These findings
in combination generated a sensitivity of 50% and specificity of
87% in differentiating H1N1(2009) from non-influenza illnesses.
The positive LR of both current WHO and CDC ILI criteria were
modest in aiding H1N1(2009) diagnosis (3.8 and 2.5 respectively)
and seasonal influenza (4.5 and 3.1 respectively). By AUROC
analyses, the addition of complete blood count criteria and chest
radiograph results to a combination of clinical predictors allowed
for greater diagnostic accuracy. The absence of leukocytosis
(defined as leucocytes ,9.3610ˆ9/L) in particular, was the best
laboratory criteria that improved the specificity and positive LR of
present WHO and CDC ILI criteria. The combination of WHO
ILI criteria with the absence of leukocytosis had a positive LR of
7.8 (95%CI 3.5–17.5) in diagnosing H1N1(2009) and 9.2 (95%CI
4.1–20.3) for seasonal influenza.
Discussion
The clinical spectrum of H1N1(2009) is still being defined in
different populations and clinical settings. Although the clinical
features of patients with influenza during outbreaks have
previously been described [8,9], data on the differences in clinical
presentation between H1N1(2009), seasonal influenza and ARIs
are sparse. Previous reports of influenza have noted clinical
dissimilarities in the observed presentation and course of influenza
infection between various influenza subtypes [10,11,12].
This study provides comparative evidence that the initial
presentation of novel H1N1(2009) in adults does not differ
significantly from that of contemporary seasonal influenza—the
majority (83 percent) of which were influenza A (H3N2). With the
exception of lymphopenia, the presenting symptoms, clinical
findings, radiographic and basic laboratory results of the two
infections were largely similar. Our findings on H1N1(2009) are
both reassuring and mostly consistent with information published
to date [1,2,13,14]. In our series however, gastrointestinal (GI)
symptoms did not feature prominently among H1N1(2009) cases;
this is in contrast to earlier clinical observations where GI
symptoms have been noted in a high percentage (25 to 38 percent)
of cases and findings in animal models suggesting greater viral
Table 3. Univariate and multivariate analyses comparing H1N1(2009) and ARI patients.
Patient characteristics Univariate analysis
Multivariate analysis, symptoms
only
Multivariate analysis with lab &
CXR
Crude OR (95% CI) p-Value Adjusted OR (95% CI) p-Value Adjusted OR (95% CI) p-Value
Constitutional
symptoms, %
Self-reported feverishness/
chills/rigors
6.5 (3.2–13.4) ,0.001 4.0 (1.8–9.0) 0.001 3.8 (1.6–9.0) 0.003
Headache 2.1 (0.9–4.8) 0.075 - 2.8 (0.9–9.1) 0.083
Myalgia 1.2 (0.5–2.7) 0.674 - -
Lethargy/malaise 0.8 (0.2–3.0) 0.734 - -
Nausea/vomitting/anorexia 0.1 (0.0–0.6) 0.007 0.1 (0.0–0.4) 0.002 0.1 (0.0–0.3) 0.002
Respiratory
symptoms, %
Cough 2.3 (1.2–4.4) 0.009 2.0 (0.9–4.3) 0.073 2.2 (1.0–5.0) 0.057
Sorethroat 0.8 (0.4–1.3) 0.321 - -
Rhinorrhea/nasal congestion 1.9 (1.1–3.3) 0.024 2.5 (1.3–5.1) 0.009 2.5 (1.2–5.3) 0.018
Body temperature
cut-off points
T$38.1uC 6.5 (3.4–12.5) ,0.001 6.4 (2.8–14.4) ,0.001 6.7 (2.7–16.7) ,0.001
T$37.8uC 4.2 (2.3–7.5) ,0.001 - -
T$37.5uC 4.8 (2.6–8.7) ,0.001 - -
Laboratory and
radiological findings
Absence of leucocytosis
(leucocytes .9.3610ˆ9/L)
5.0 (2.5–10.2) ,0.001 - 4.5 (1.9–10.7) 0.001
Lymphopenia (lymphocytes
,0.9610ˆ9/L)
2.6 (1.3–5.1) 0.006 - -
Normal chest radiograph 3.3 (1.0–10.5) 0.047 - 6.2 (1.2–30.6) 0.026
doi:10.1371/journal.pone.0008453.t003
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common a finding in H1N1(2009) infections as compared to
seasonal influenza. This could be attributable to the greater degree
of lymphopenia previously described in A(H3N2) infections [10], a
subtype that comprised the major putative agent in our seasonal
influenza group.
Beyond the clinical presentation, our study also explored the
accuracy of various clinical predictors for the diagnosis of
H1N1(2009) in a population of adult patients with acute
respiratory illness. No single clinical finding had a positive LR
high enough to discriminate for H1N1(2009) nor a negative LR
low enough to exclude it. On multivariate analysis, a fever greater
than 38uC, feverishness (chills, rigors, or self-reported feverish-
ness), rhinorrhea, a normal chest radiograph and the absence of
leukocytosis and significant gastrointestinal symptoms were all
positively associated with H1N1(2009) infection. Most of the
factors which predicted H1N1(2009) infection in comparison with
acute respiratory illnesses were also found to be relevant for
seasonal influenza. Again, no single clinical finding had sufficient
high positive LR or low negative LR, but with the WHO ILI
criteria in combination with the absence of leukocytosis gave
reasonably high LRP for seasonal influenza.
It is appreciated that the sensitivity of clinical predictors for
influenza varies depending on a multitude of factors including the
prevalence of disease, age, underlying illnesses, duration of
symptoms prior to consultation, and the vaccination rate in the
population tested. Published data to date have shown varying
positive predictive values with the use of fever and cough as clinical
predictors, ranging from 35 to 83 percent [4,8,16,17]. Most of
these studies have been conducted in the setting of community
outbreaks of seasonal influenza. In our analysis, current CDC and
WHO criteria for ILI are both fairly specific for H1N1(2009) but
have only modest positive LRs in our influenza PCR-confirmed
population. The WHO criterion with a higher temperature cut-off
Table 4. Univariate and multivariate analyses comparing seasonal influenza and ARI patients.
Patient characteristics Univariate analysis
Multivariate analysis, symptoms
only
Multivariate analysis with lab &
CXR
Crude OR (95% CI) p-Value Adjusted OR (95% CI) p-Value Adjusted OR (95% CI) p-Value
Constitutional
symptoms, %
Self-reported feverishness/
chills/rigors
10.2 (4.5–23.2) ,0.001 7.7 (3.1–19.2) ,0.001 5.6 (2.0–15.9) 0.001
Headache 1.6 (0.7–3.7) 0.288 - -
Myalgia 2.2 (1–4.7) 0.044 - -
Lethargy/malaise 0.4 (0.07–2.0) 0.264 - -
Nausea/vomitting/anorexia 0.5 (0.2–1.2) 0.113 - -
Respiratory
symptoms, %
Cough 3.1 (1.6–6.0) 0.001 3.7 (1.7–8.5) 0.002 4.0 (1.6–10.3) 0.003
Sorethroat 1.1 (0.6–2.0) 0.666 - -
Rhinorrhea/nasal congestion 1.8 (1.0–3.2) 0.034 2.4 (1.2–5.0) 0.014 2.3 (1.0–5.0) 0.040
Body temperature
cut-off points
T$38.1uC 8.3 (4.3–16.1) ,0.001 5.8 (2.8–12.1) ,0.001 4.8 (2.0–11.7) 0.001
T$37.8uC 7.0 (3.7–13.0) ,0.001 - -
T$37.5uC 6.8 (3.6–13.1) ,0.001 - -
Laboratory and
radiological findings
Absence of leucocytosis
(leucocytes .9.3610ˆ9/L)
8.7 (3.8–19.8) ,0.001 - 8.5 (3.0–23.7) ,0.001
Lymphopenia (lymphocytes
,0.9610ˆ9/L)
6.4 (3.3–12.5) ,0.001 - 3.1 (1.2–7.7) 0.018
Normal chest radiograph 2.6 (0.9–7.7) 0.085 - 3.6 (0.8–15.9) 0.088
doi:10.1371/journal.pone.0008453.t004
Figure 2. Receiver operating characteristic curves. (A) H1N1 versus
acute respiratory illness, where Area under the receiver operating
characteristic curve (AUROC) values are 0.839 for multivariate logistic
regressionmodelusingsymptoms andsignsonly, and0.874whenadding
laboratory and chest radiograph (CXR) findings. (B) seasonal influenza
versusacuterespiratory illness.AUROCvalues are 0.842forsymptomsand
signs only, and 0.893 when adding laboratory and CXR findings.
doi:10.1371/journal.pone.0008453.g002
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PLoS ONE | www.plosone.org 8 December 2009 | Volume 4 | Issue 12 | e8453was predictably more specific and accurate in ruling in a diagnosis
of H1N1(2009) than present CDC ILI criteria. The addition of
routine laboratory test results such as a complete blood count or
chest radiographs expectedly increases the specificity and positive
predictive value of these ILI definitions. In particular, the absence
of leukocytosis added the greatest discriminatory power when
combined with the WHO ILI definition. The use of such a
modified ILI definition would be of special practical benefit in
settings that screen for influenza (including H1N1(2009)) and have
facilities for basic hematological testing, such as emergency rooms
and primary care facilities. Although influenza can be diagnosed
with commercially available rapid test kits, the sensitivity of
such test kits have been shown to be low in some reports
[18,19,20,21,22,23]. Augmenting current clinical criteria with
additional laboratory criteria—specifically the absence of leuko-
cytosis—will allow for greater accuracy in distinguishing influenza
from other acute respiratory illnesses and permit the earlier
initiation of appropriate therapy and public health measures.
The limitations of our study include the lack of evaluative
vaccination history data and the retrospective nature of our data
collection. Also, our analyzed population comprised mainly
outpatient young adults thereby precluding the extrapolation our
results to pediatric patients and those in special settings.
Our analysis demonstrates that the clinical presentation of
H1N1(2009) infection is largely indistinguishable from that of
seasonal influenza. However among patients with acute respira-
tory illness, features such as a temperature greater than 38uC,
rhinorrhea, a normal chest radiograph, and the absence of
leukocytosis or significant gastrointestinal symptoms were all
positively associated with H1N1(2009) and seasonal influenza
infection. The use of enhanced ILI criteria in certain settings, that
combine both a symptom complex with the absence of
leukocytosis on basic laboratory testing, can considerably improve
the accuracy of establishing the diagnosis of influenza.
Author Contributions
Conceived and designed the experiments: AO MIC LL YSL. Performed
the experiments: TB SYT. Analyzed the data: AO MIC LL AT NWN.
Contributed reagents/materials/analysis tools: AT NWN TB SYT YSL.
Wrote the paper: AO LL.
References
1. World Health Organization (2009) Human infection with new influenza A
(H1N1) virus: clinical observations from Mexico and other affected countries,
May 2009. Wkly Epidemiol Rec 84: 185–189.
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence
of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:
2605–2615.
3. Ong AK, Hayden FG (2007) John F. Enders lecture 2006: antivirals for
influenza. J Infect Dis 196: 181–190.
4. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP (2005)
Does this patient have influenza? JAMA 293: 987–997.
5. Ministry of Health (2009) MOH Circular 34/2009: Public health measures for
public sector hospitals & national centres: Swine Influenza A (H1N1). Singapore:
MOH.
6. Ministry of Health (2009) MOH Circular 79/2009: Updates on management of
Influenza A (H1N1-2009). Singapore: MOH.
7. Jaeschke R, Guyatt GH, Sackett DL (1994) Users’ guides to the medical
literature. III. How to use an article about a diagnostic test. B. What are the
results and will they help me in caring for my patients? The Evidence-Based
Medicine Working Group. JAMA 271: 703–707.
8. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J (2000) Clinical
signs and symptoms predicting influenza infection. Arch Intern Med 160:
3243–3247.
9. Sugaya N, Kusumoto N, Suzuki Y, Nerome R, Nerome K (1996) Large
sequential outbreaks caused by influenza A (H3N2) and B viruses in an
institution for the mentally handicapped. J Med Virol 50: 120–125.
10. Kaji M, Watanabe A, Aizawa H (2003) Differences in clinical features between
influenza A H1N1, A H3N2, and B in adult patients. Respirology 8: 231–233.
11. Kerr AA, McQuillin J, Downham MA, Gardner PS (1975) Gastric ’flu influenza
B causing abdominal symptons in children. Lancet 1: 291–295.
12. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, et al. (2009) Clinical
features of human influenza A (H5N1) infection in Vietnam: 2004–2006. Clin
Infect Dis 48: 1639–1646.
13. World Health Organization (2009) Human infection with new influenza A
(H1N1) virus: clinical observations from a school-associated outbreak in Kobe,
Japan, May 2009. Wkly Epidemiol Rec 84: 237–244.
14. World Health Organization (2009) Human infection with new influenza A
(H1N1) virus: Mexico, update, March-May 2009. Wkly Epidemiol Rec 84:
213–219.
15. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, et al. (2009)
Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza
Viruses in Ferrets and Mice. Science 325: 484–487.
16. Boivin G, Hardy I, Tellier G, Maziade J (2000) Predicting influenza infections
during epidemics with use of a clinical case definition. Clin Infect Dis 31:
1166–1169.
17. Ohmit SE, Monto AS (2006) Symptomatic predictors of influenza virus positivity
in children during the influenza season. Clin Infect Dis 43: 564–568.
18. Centers for Disease Control (2009) Evaluation of rapid influenza diagnostic tests
for detection of novel influenza A (H1N1) Virus - United States, 2009. MMWR
Morb Mortal Wkly Rep 58: 826–829.
19. Chan KH, Lai ST, Poon LL, Guan Y, Yuen KY, et al. (2009) Analytical
sensitivity of rapid influenza antigen detection tests for swine-origin influenza
virus (H1N1). J Clin Virol 45: 205–207.
20. Chan KH, Lam SY, Puthavathana P, Nguyen TD, Long HT, et al. (2007)
Comparative analytical sensitivities of six rapid influenza A antigen detection test
kits for detection of influenza A subtypes H1N1, H3N2 and H5N1. J Clin Virol
38: 169–171.
21. Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG (2007) Performance of six
influenza rapid tests in detecting human influenza in clinical specimens. J Clin
Virol 39: 132–135.
22. Uyeki TM (2003) Influenza diagnosis and treatment in children: a review of
studies on clinically useful tests and antiviral treatment for influenza. Pediatr
Infect Dis J 22: 164–177.
23. Uyeki TM, Prasad R, Vukotich C, Stebbins S, Rinaldo CR, et al. (2009) Low
sensitivity of rapid diagnostic test for influenza. Clin Infect Dis 48: e89–92.
Diagnosis of Influenza
PLoS ONE | www.plosone.org 9 December 2009 | Volume 4 | Issue 12 | e8453